BDS offers analyses that specifically target dioxins, dioxin-like PCBs, non-dioxin-like PCBs,PAHs and PFASs. In addition to the targeted screening for these toxic compounds, CALUX® assays are also used in screenings for potentially adverse biological activities, like endocrine- or genotoxic effects.
The presence of dioxins and PCBs in food and feed is subjected to international regulations. The EU has laid down general requirements for the determination of dioxins and dioxin-like PCBs in food and feed using cell-based bioassays. The DR CALUX bioassay (dioxins / furans and dioxine-like-PCBs) fully complies with these stringent requirements and is ISO 17025 accredited (registration number RvA L401). For samples that are suspected based on the DR CALUX results, we offer confirmative analysis by -MS/MS. Analysis of non dioxin-like PCBs is performed by chemical analysis (GC-MS/MS) only; ISO 17025 (RvA L401) accredited).